SKI Market

Indian Indices

Sensex

82,615.46 117.32
( 0.14%)

Global Indices

Nasdaq

49,410.74 -272.93
(-0.55%)

Dow Jones

6,881.90 -20.41
(-0.30%)

Hang Seng

57,519.13 375.29
(0.66%)

Nikkei 225

10,620.33 -65.85
(-0.62%)

Forex

USD-INR

90.70 0.01
(0.01%)

EUR-INR

107.23 -0.14
(-0.13%)

GBP-INR

122.83 -0.27
(-0.22%)

JPY-INR

0.59 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

43.67

8010.27

EPS(TTM)

Face Value()

Div & Yield %

19.9

0.46

Back

Shree Digvijay Cement Co. consolidated net profit rises 2520.51% in the September 2025 quarter

Oct 17,2025

Net profit of Shree Digvijay Cement Co. rose 2520.51% to Rs 10.22 crore in the quarter ended September 2025 as against Rs 0.39 crore during the previous quarter ended September 2024. Sales rose 11.14% to Rs 161.35 crore in the quarter ended September 2025 as against Rs 145.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	161.35	145.18	11
OPM %	12.04	5.58	-
PBDT	19.85	8.27	140
PBT	13.65	0.74	1745
NP	10.22	0.39	2521

82,615.46 117.32 ( 0.14%)

49,410.74 -272.93 (-0.55%)

6,881.90 -20.41 (-0.30%)

57,519.13 375.29 (0.66%)

10,620.33 -65.85 (-0.62%)

90.70 0.01 (0.01%)

107.23 -0.14 (-0.13%)

122.83 -0.27 (-0.22%)

0.59 0.00 (-0.51%)